NTT4 Polyclonal Antibody

活动价:

¥680.00

市场价:¥880.00

一键复制产品信息
产品规格:
  • 50μL
  • 100μL
货号:

FAB2616945

  • 产品信息
  • 注意事项
  • 实验验证
  • 产品声明
  • 引用文献
  • 相关产品
  • 文件下载
商品描述
  • 靶点-Target

    NTT4

  • 反应性

    Human,Mouse,Rat

  • 应用

    WB,ELISA

  • 宿主物种-Host Species

    Rabbit

  • 同种型-Isotype

    IgG

  • 修饰-Modification

    Unmodified

  • MW(Observed)

    81kD

  • 推荐稀释比

    WB 1:500-1:2000;ELISA 1:5000;Not yet tested in other applications.

  • 组成

    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

  • 纯化工艺

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

  • 储存

    -15°C to -25°C/1 year(Do not lower than -25°C)

  • 浓度

    1 mg/ml

  • 克隆性

    Polyclonal

  • 免疫原

    Synthesized peptide derived from NTT4 . at AA range: 240-320

  • 特异性

    NTT4 Polyclonal Antibody detects endogenous levels of NTT4 protein.

  • 基因名称

    SLC6A17

  • 蛋白名称

    Sodium-dependent neutral amino acid transporter SLC6A17

  • 别名

    SLC6A17;NTT4;Sodium-dependent neutral amino acid transporter SLC6A17;Sodium-dependent neurotransmitter transporter NTT4;Solute carrier family 6 member 17

  • Organism-1

    Human

  • 基因ID-1

    388662

  • SwissProt-1

    Q9H1V8

  • Organism-2

    Mouse

  • 基因ID-2

    229706

  • SwissProt-2

    Q8BJI1

  • Organism-3

    Rat

  • 基因ID-3

    613226

  • SwissProt-3

    P31662

  • 背景

    The SLC6 family of proteins, which includes SLC6A17, acts as specific transporters for neurotransmitters, amino acids, and osmolytes like betaine, taurine, and creatine. SLC6 proteins are sodium cotransporters that derive the energy for solute transport from the electrochemical gradient for sodium ions (Hoglund et al., 2005 [PubMed 16125675]).[supplied by OMIM, Mar 2008],

  • 细胞定位

    Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane ; Multi-pass membrane protein . Cell junction, synapse, postsynapse . Cell junction, synapse, presynapse . Localizes at synaptic junctions - at both pre- and post-synaptic sites - particularly in excitatory glutamatergic terminals. .